Letter: TIPSS and reversal of sarcopenia
- PMID: 33333603
- DOI: 10.1111/apt.16129
Letter: TIPSS and reversal of sarcopenia
Comment in
-
Letter: TIPSS is a promising therapy for sarcopenia in cirrhosis.Aliment Pharmacol Ther. 2021 Jan;53(1):209. doi: 10.1111/apt.16128. Aliment Pharmacol Ther. 2021. PMID: 33333606 No abstract available.
Comment on
-
Consequences of TIPSS placement on the body composition of patients with cirrhosis and severe portal hypertension: a large retrospective CT-based surveillance.Aliment Pharmacol Ther. 2020 Nov;52(9):1516-1526. doi: 10.1111/apt.16080. Epub 2020 Sep 15. Aliment Pharmacol Ther. 2020. PMID: 32931618
-
Letter: TIPSS is a promising therapy for sarcopenia in cirrhosis.Aliment Pharmacol Ther. 2021 Jan;53(1):209. doi: 10.1111/apt.16128. Aliment Pharmacol Ther. 2021. PMID: 33333606 No abstract available.
-
TIPSS and reversal of sarcopenia, and TIPSS is a promising therapy for sarcopenia in cirrhosis-Authors' reply.Aliment Pharmacol Ther. 2021 Jan;53(1):211-212. doi: 10.1111/apt.16152. Aliment Pharmacol Ther. 2021. PMID: 33333608 No abstract available.
Similar articles
-
TIPSS and reversal of sarcopenia, and TIPSS is a promising therapy for sarcopenia in cirrhosis-Authors' reply.Aliment Pharmacol Ther. 2021 Jan;53(1):211-212. doi: 10.1111/apt.16152. Aliment Pharmacol Ther. 2021. PMID: 33333608 No abstract available.
-
Letter: TIPSS is a promising therapy for sarcopenia in cirrhosis.Aliment Pharmacol Ther. 2021 Jan;53(1):209. doi: 10.1111/apt.16128. Aliment Pharmacol Ther. 2021. PMID: 33333606 No abstract available.
-
Letter: the improvement of sarcopenia after TIPSS might result from the survivor bias-authors' reply.Aliment Pharmacol Ther. 2021 Mar;53(5):677-678. doi: 10.1111/apt.16274. Aliment Pharmacol Ther. 2021. PMID: 33566422 No abstract available.
-
[Ultrasound guided puncture of the portal vein in transjugular intrahepatic portasystemic stent shunt (TIPSS)].Radiologe. 1996 Sep;36(9):677-82. doi: 10.1007/s001170050127. Radiologe. 1996. PMID: 8999442 Review. German.
-
[Transjugular portosystemic stent shunt (TIPSS) as intervention in clinical complications of portal hypertension].Radiologe. 2001 Oct;41(10):877-83. doi: 10.1007/s001170170058. Radiologe. 2001. PMID: 11715578 Review. German.
References
REFERENCES
-
- Artru F, Miquet X, Azahaf M, et al. Consequences of TIPSS placement on the body composition of patients with cirrhosis and severe portal hypertension: a large retrospective CT-based surveillance. Aliment Pharmacol Ther. 2020;52:1516-1526.
-
- Dasarathy S, Hatzoglou M. Hyperammonemia and proteostasis in cirrhosis. Curr Opin Clin Nutr Metab Care. 2018;21(1):30-36. https://doi.org/10.1097/mco.0000000000000426
-
- Kumar A, Davuluri G, Silva RNE, et al. Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis. Hepatology. 2017;65:2045-2058.
-
- Nolte W, Wiltfang J, Schindler C, et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology. 1998;28:1215-1225. https://doi.org/10.1002/hep.510280508